Literature DB >> 31733683

Check Point Inhibitors and Their Role in Immunosuppression in Sepsis.

Michelle E Wakeley1, Chyna C Gray2, Sean F Monaghan3, Daithi S Heffernan4, Alfred Ayala5.   

Abstract

Checkpoint regulators are a group of membrane-bound receptors or ligands expressed on immune cells to regulate the immune cell response to antigen presentation and other immune stimuli, such as cytokines, chemokines, and complement. In the context of profound immune activation, such as sepsis, the immune system can be rendered anergic by these receptors to prevent excessive inflammation and tissue damage. If this septic immunosuppression is prolonged, the host is unable to mount the appropriate immune response to a secondary insult or infection. This article describes the manner in which major regulators in the B7-CD28 family and their ligands mediate immunosuppression in sepsis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTLA-4; Checkpoint regulators; HVEM; Immunosuppression; PD-1; Sepsis; VISTA

Mesh:

Substances:

Year:  2019        PMID: 31733683      PMCID: PMC6863093          DOI: 10.1016/j.ccc.2019.08.006

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  85 in total

1.  A new analysis of allogeneic interactions.

Authors:  K J Lafferty; A J Cunningham
Journal:  Aust J Exp Biol Med Sci       Date:  1975-02

2.  Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data.

Authors:  Chanu Rhee; Michael V Murphy; Lingling Li; Richard Platt; Michael Klompas
Journal:  Clin Infect Dis       Date:  2014-09-25       Impact factor: 9.079

3.  LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection.

Authors:  Goo-Young Seo; Jr-Wen Shui; Daisuke Takahashi; Christina Song; Qingyang Wang; Kenneth Kim; Zbigniew Mikulski; Shilpi Chandra; Daniel A Giles; Sonja Zahner; Pyeung-Hyeun Kim; Hilde Cheroutre; Marco Colonna; Mitchell Kronenberg
Journal:  Cell Host Microbe       Date:  2018-08-08       Impact factor: 21.023

4.  Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.

Authors:  Stefanie Kirchberger; Otto Majdic; Peter Steinberger; Stefan Blüml; Katharina Pfistershammer; Gerhard Zlabinger; Luiza Deszcz; Ernst Kuechler; Walter Knapp; Johannes Stöckl
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

5.  Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor, programmed death-1.

Authors:  Sean F Monaghan; Rajan K Thakkar; Daithi S Heffernan; Xin Huang; Chun-Shiang Chung; Joanne Lomas-Neira; William G Cioffi; Alfred Ayala
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

6.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

7.  Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas.

Authors:  Takeshi Watanabe; Takako Suda; Takuya Tsunoda; Naotaka Uchida; Katsuaki Ura; Tatsushi Kato; Suguru Hasegawa; Seiji Satoh; Shigetsugu Ohgi; Hideaki Tahara; Yoichi Furukawa; Yusuke Nakamura
Journal:  Cancer Sci       Date:  2005-08       Impact factor: 6.716

Review 8.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

9.  Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.

Authors:  Woo-Sung Chang; Ji-Yeon Kim; Yeon-Jeong Kim; Yun-Sun Kim; Jung-Mi Lee; Miyuki Azuma; Hideo Yagita; Chang-Yuil Kang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 10.  The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.

Authors:  Guifang Cai; Gordon J Freeman
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more
  9 in total

1.  A Whole Blood Enzyme-Linked Immunospot Assay for Functional Immune Endotyping of Septic Patients.

Authors:  Monty B Mazer; Charles C Caldwell; Jodi Hanson; Daniel Mannion; Isaiah R Turnbull; Anne Drewry; Dale Osborne; Andrew Walton; Tessa Blood; Lyle L Moldawer; Scott Brakenridge; Kenneth E Remy; Richard S Hotchkiss
Journal:  J Immunol       Date:  2020-11-25       Impact factor: 5.422

2.  Glycolysis-Related Gene Signature Can Predict Survival and Immune Status of Hepatocellular Carcinoma.

Authors:  Qian Xu; Dan Miao; Xian Song; Zhuoyan Chen; Liuwei Zeng; Luying Zhao; Jun Xu; Zhuo Lin; Fujun Yu
Journal:  Ann Surg Oncol       Date:  2022-03-09       Impact factor: 5.344

3.  Profiling the Expression of Circulating Acute-Phase Proteins, Cytokines, and Checkpoint Proteins in Patients with Severe Trauma: A Pilot Study.

Authors:  Shao-Chun Wu; Cheng-Shyuan Rau; Pao-Jen Kuo; Fu-Yuan Shih; Hui-Ping Lin; Yi-Chan Wu; Ting-Min Hsieh; Hang-Tsung Liu; Ching-Hua Hsieh
Journal:  J Inflamm Res       Date:  2021-08-06

4.  Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases.

Authors:  Andreas von Knethen; Jose-Ignacio Rodriguez-Barbosa
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

Review 5.  The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies.

Authors:  Victoria C Brom; Christof Burger; Dieter C Wirtz; Frank A Schildberg
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  SHP2 inhibitor PHPS1 ameliorates acute kidney injury by Erk1/2-STAT3 signaling in a combined murine hemorrhage followed by septic challenge model.

Authors:  Jihong Jiang; Baoji Hu; Chun-Shiang Chung; Yaping Chen; Yunhe Zhang; Elizabeth W Tindal; Jinbao Li; Alfred Ayala
Journal:  Mol Med       Date:  2020-09-21       Impact factor: 6.354

7.  Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.

Authors:  Yini Sun; Jerome C Anyalebechi; He Sun; Tetsuya Yumoto; Ming Xue; Danya Liu; Zhe Liang; Craig M Coopersmith; Mandy L Ford
Journal:  JCI Insight       Date:  2021-03-08

8.  Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.

Authors:  Jiasheng Lei; Dengyong Zhang; Chao Yao; Sheng Ding; Zheng Lu
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

9.  High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.

Authors:  Tianzhu Tao; Lulong Bo; Teng Li; Longbao Shi; Hui Zhang; Bo Ye; Yuhai Xu; Qingqing Ma; Xiaoming Deng; Guorong Zhang
Journal:  Mediators Inflamm       Date:  2021-07-28       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.